fda staff are involved in many activities intended to build regulatory science knowledge , facilitate collaborations and partnerships with stakeholders , and establish a flexible , product - focused , science - based approach to regulation of products that involve nanomaterials or applications of nanotechnology . we undertake these efforts to facilitate innovation , help ensure timely and clear communication regarding fda nanotechnology activities , and to fulfill fda mission to safeguard the public health . for more information about specific activities , see :